denmark

Anthill Cloud: Transforming Pharma Marketing with AI, Modular Content, and Omnichannel Engagement

COPENHAGEN, Denmark, Nov. 3, 2025 /PRNewswire/ -- Anthill , a leading content excellence and technology partner to the life sciences industry,…

2 days ago

Bavarian Nordic Provides Clarification on the HERA Framework Agreement and the Public Preparedness Business

COPENHAGEN, Denmark, November 1, 2025 – Bavarian Nordic A/S hereby issues the following clarification regarding the Health Emergency Preparedness and…

4 days ago

Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer

Media Release COPENHAGEN, Denmark; October 18, 2025 Updated data from the Phase 1/2 RAINFOL™-01 trial showed rinatabart sesutecan (Rina-S®) 100…

3 weeks ago

Novo Nordisks oral semaglutide 25 mg (Wegovy in a pill*) delivered 16.6% weight loss in people with obesity in a newly published study

Oral semaglutide 25 mg (the once-daily pill formulation of Wegovy®) achieved significant weight loss, with one in three study participants…

2 months ago

People taking Novo Nordisks Wegovy experienced reduced food noise and boosted mental well-being

Results from a real-world survey suggest that semaglutide for weight management (Wegovy®) helped suppress food noise – unwanted and intrusive…

2 months ago

SimCorp to transform private market investing with SimCorp Alternatives

Highlights: SimCorp launches SimCorp Alternatives, a comprehensive offering designed to serve the needs of all alternative investment firms. It builds…

2 months ago

ZEISS showcases expansion of ophthalmic care options creating industry-leading workflow solutions; marks new refractive and cataract milestones

ZEISS Medical Technology will showcase new ophthalmic innovations and market milestones at ESCRS from Sept. 12 - 15 in Copenhagen,…

2 months ago

Novo Nordisk A/S: Wegovy approved in the US for the treatment of MASH

Bagsværd, Denmark, 15 August 2025 – Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved an…

3 months ago

SimCorp names Peter Sanderson as Chief Executive Officer

Sanderson has proven track record of driving growth and deep industry knowledge Sanderson has held key leadership roles at GAM Investments,…

3 months ago

Novo Nordisk A/S: Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with haemophilia A in new phase 3 data presented at the ISTH 2025 Congress

New FRONTIER5 data show that a direct switch to investigational Mim8 (denecimig) prophylaxis treatment from emicizumab, without the need for…

5 months ago